XZEC:XETRA:XETRA-Xtrackers MSCI Europe Consumer Discretionary ESG Screened UCITS ETF (EUR)

ETF | Others |

Last Closing

USD 64.7

Change

0.00 (0.00)%

Market Cap

USD 7.18M

Volume

2.00

Analyst Target

N/A
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-04-28 )

Largest Industry Peers for Others

Symbol Name Price(Change) Market Cap
XM1D:XETRA Xtrackers MSCI Japan UCITS ETF..

+0.06 (+0.11%)

USD 448.39B
LCUJ:XETRA Lyxor Core MSCI Japan (DR) UCI..

+0.02 (+0.13%)

USD 191.96B
PRAJ:XETRA Amundi Index Solutions - Amund..

+0.01 (+0.02%)

USD 177.46B
PR1J:XETRA Amundi Prime Japan UCITS ETF D..

+0.02 (+0.06%)

USD 177.46B
XDJP:XETRA Xtrackers Nikkei 225 UCITS ETF..

+0.04 (+0.15%)

USD 157.79B
TM5:XETRA T-MOBILE US INC.DL-00001

-0.18 (-0.12%)

USD 126.93B
JARI:XETRA Amundi Index Solutions - Amund..

+0.07 (+0.15%)

USD 102.57B
8R80:XETRA Amundi Index Solutions - Amund..

+0.80 (+0.57%)

USD 102.14B
UIM5:XETRA UBS (Lux) Fund Solutions - MSC..

+0.05 (+0.09%)

USD 85.64B
SXR8:XETRA iShares Core S&P 500 UCITS ETF..

-0.60 (-0.12%)

USD 80.38B

ETFs Containing XZEC:XETRA

N/A

Market Performance

  Market Performance vs. Industry/Classification (Others) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 8.87% 77% C+ 75% C
Dividend Return N/A N/A N/A N/A N/A
Total Return 8.87% 77% C+ 75% C
Trailing 12 Months  
Capital Gain 4.42% 38% F 43% F
Dividend Return N/A N/A N/A N/A N/A
Total Return 4.42% 37% F 42% F
Trailing 5 Years  
Capital Gain N/A N/A N/A N/A N/A
Dividend Return N/A N/A N/A N/A N/A
Total Return N/A N/A N/A N/A N/A
Average Annual (5 Year Horizon)  
Capital Gain 9.06% 73% C 70% C-
Dividend Return 9.06% 72% C 69% C-
Total Return N/A N/A N/A N/A N/A
Risk Return Profile  
Volatility (Standard Deviation) 10.93% 58% F 67% D+
Risk Adjusted Return 82.94% 94% A 94% A
Market Capitalization 7.18M 7% C- 6% D-

Annual Financials (EUR)

Quarterly Financials (EUR)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Superior risk adjusted returns

This stock has performed well, on a risk adjusted basis, compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile.

What to not like:
Low market capitalization

This is among the smaller entities in its sectors with below median market capitalization. That may make it less stable in the long run unless it has a unique technology or market which can help it grow or get acquired in future.